节点文献

131I治疗毒性甲状腺肿合并肝损害27例临床观察

27 clinical survey of 131I cure Graves disease combined with liver damage

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨维珍陈勇耿建

【Author】 YANG Wei-zhen,CHEN Yong,GENG Jian.Department of Surgery,Datong Railway Center Hospital,Datong,Shanxi,037005,China

【机构】 大同铁路中心医院外科大同铁路中心医院外科

【摘要】 目的观察131I治疗毒性甲状腺肿(Graves)合并肝损害患者的临床疗效。方法对27例Graves合并肝损害进行131I治疗(3、6、12、24个月),观察肝功能及临床表现的变化。结果Graves合并肝损害131I治疗后肝功能明显改善,相应的症状明显改善。结论核素131I是治疗毒性甲状腺肿合并肝损害的一种安全、简便、费用低、远期疗效好、副作用小、患者易接受的有效方法。

【Abstract】 Objective To observe liver function improvement of Grave’s disease combined with liver damage after 131I cure.Methods We observed patients of Graves disease combined with liver damage on diffevent times after 131I cure(3,6,12,24 months after 131I cure) and at the same time we monitored liver function.Results The liver function and clinical expression of the patients who had Graves disease combined with liver damage improved vemarkably after 131I cure.Conclusion 131I cure Graves patients combined with liver damage is safe and simple and has long-term effect.It’s side effect is little and is apt to be accepted by patients.

【关键词】 核医学甲状腺功能亢进症肝损害
【Key words】 Nuclear medicineHyperthyroidismLiver damage
  • 【文献出处】 中国基层医药 ,Chinese Journal of Primary Medicine and Pharmacy , 编辑部邮箱 ,2006年01期
  • 【分类号】R581.3
  • 【下载频次】37
节点文献中: 

本文链接的文献网络图示:

本文的引文网络